Table 1 Percentage of plasmid injected zebrafish expressing GFP in different body tissues after exposure to oestrogens (at 72 hpf)
|  | Control | EE2 (ng/L) | E2 (ng/L) | NP (μg/L) | |||
|---|---|---|---|---|---|---|---|
1000 | 100 | 10 | 1000 | 100 | 10 | ||
Liver | 0 | 74.3% (223/300) | 61.6% (185/300) | 0 | 70.7% (212/300) | 18.7% (56/300) | 0 |
Heart | 0 | 82.7% (248/300) | 66.3% (199/300) | 0 | 78% (234/300) | 65% (195/300) | 56% (168/300) |
Muscle | 13.3% (40/300) | 90.3% (271/300) | 78.3% (235/300) | 27.3% (82/300) | 87% (261/300) | 74% (222/300) | 71.3% (214/300) |
Forebrain | Â | 33% (99/300) | 0 | 0 | 25.6% (77/300) | 0 | 0 |
Otic vesicle | 19% (47/300) | 26.3% (78/300) | 16.6% (50/300) | 10.6% (32/300) | 27% (81/300) | 25.3% (76/300) | 0 |
lateral line neuromast | 10% (32/300) | 22.3% (67/300) | 13% (39/300) | 14.7% (44/300) | 25.3% (76/300) | 18% (54/300) | 4% (12/300) |